March 2014, Vol. 104, No. 3 developed wound healing complications had higher levels of cotinine than those who did not when tested peri-operatively. [1] [2] [3] A study by Coon et al. [1] demonstrated that patients who claimed to have quit smoking were particularly likely to be deceitful, and a cost saving strategy may be employed whereby only this group is tested. In their cohort of plastic surgery patients, the test would detect 1 out of 10 'former' smokers, as opposed to 1 in 66 of all patients in a selfreported non-smoking population.
We believe that routine or selective serum or urine cotinine testing will enable us to stratify risk in both elective and reconstructive scenarios. Many procedures will therefore be cancelled, or at least delayed pending smoking cessation, which may have remarkable cost benefits for health systems, especially one as stretched as ours. Theatre time has been reduced in recent years despite increasing demand, and funding has inexplicably been diverted away from specialist surgical services.
The onus is on surgeons to be far stricter when applying absolute and relative contraindications, such as smoking, to elective surgery. Denying a patient a procedure s/he requires may also provide just the incentive needed to stop smoking. 
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